The results showed that asthma sensitivity was reduced in IRF7−/− mice by the drug inhibition of RIPK1- or MLKL-induced tracheal smooth muscle remodeling, mucus hypersecretion, and reduced eosinophilic inflammation. The gene discussed is MLKL; the disease is asthma.